Onconetix appointed David White as Chief Executive Officer effective March 18, 2026, and added Sammy Dorf to its board of directors and audit committee effective March 19, 2026, while outgoing interim CEO Karina Fedasz transitions to interim CFO. These appointments bolster senior management as the company moves forward with its planned Realbotix LLC acquisition.

David White brings over 30 years of executive leadership and board experience, including CEO roles at American Student Transportation Partners and TransCare Inc., and audit committee chair positions on NYSE American and TSX-listed firms. He holds an MBA from the University of Toronto, a BA from the University of Western Ontario, and is a Chartered Professional Accountant and ICD.D designee.

Sammy Dorf co-founded Verano Holdings Corp., leading its expansion and public listing, and later founded Dreamlife Consulting before joining Blue Current, LLC. He has served as executive chairman at Flora Growth Corp. and holds board roles at SRx Health Solutions and Cube Exchange, bringing deep capital markets and governance expertise to Onconetix’s audit committee.

Onconetix is advancing its definitive agreement to acquire Realbotix LLC, a US-based developer of AI-powered humanoid robots designed for enterprise and consumer use. The leadership additions are intended to guide the S-4 registration process, secure shareholder approval, and position the combined company for growth in the AI robotics sector.